Madrid, Spain

Concepcion Perez Martin



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Concepcion Perez Martin: Innovator in Medicinal Chemistry

Introduction

Concepcion Perez Martin is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target critical enzymes involved in various diseases. With a total of 3 patents, his work is paving the way for new therapeutic options.

Latest Patents

One of his latest patents focuses on heterocyclic GSK-3 allosteric modulators. This invention relates to heterocyclic substituted quinoline derivatives that act as allosteric inhibitors of the glycogen synthase kinase-3 (GSK-3) enzyme. These compounds are designed for the manufacturing of a medicament aimed at treating and preventing diseases where GSK-3 is implicated, such as neurodegenerative diseases, inflammatory diseases, cancer, and diabetes. Additionally, they promote various regenerative processes.

Career Highlights

Concepcion Perez Martin is affiliated with the Consejo Superior de Investigaciones Científicas, a prominent research institution in Spain. His work has been instrumental in advancing the understanding of GSK-3 and its role in various health conditions. His innovative approach to medicinal chemistry has garnered attention in the scientific community.

Collaborations

He has collaborated with several esteemed colleagues, including Ana Martinez Gil and Carmen Gil Ayuso-Gontan. These partnerships have further enriched his research and contributed to the development of impactful medicinal solutions.

Conclusion

Concepcion Perez Martin's contributions to medicinal chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to inspire advancements in the treatment of complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…